Institute of Evolution & Department of Evolutionary and Environmental Biology, Faculty of Natural Sciences, University of Haifa, Mount Carmel, Haifa 31905, Israel.
Appl Microbiol Biotechnol. 2011 Mar;89(5):1323-32. doi: 10.1007/s00253-010-3067-4. Epub 2010 Dec 29.
The target of the present review is to draw attention to many critically important unsolved problems in the future development of medicinal mushroom science in the twenty-first century. Special attention is paid to mushroom polysaccharides. Many, if not all, higher Basidiomycetes mushrooms contain biologically active polysaccharides in fruit bodies, cultured mycelium, and cultured broth. The data on mushroom polysaccharides are summarized for approximately 700 species of higher Hetero- and Homobasidiomycetes. The chemical structure of polysaccharides and its connection to antitumor activity, including possible ways of chemical modification, experimental testing and clinical use of antitumor or immunostimulating polysaccharides, and possible mechanisms of their biological action, are discussed. Numerous bioactive polysaccharides or polysaccharide-protein complexes from medicinal mushrooms are described that appear to enhance innate and cell-mediated immune responses and exhibit antitumor activities in animals and humans. Stimulation of host immune defense systems by bioactive polymers from medicinal mushrooms has significant effects on the maturation, differentiation, and proliferation of many kinds of immune cells in the host. Many of these mushroom polymers were reported previously to have immunotherapeutic properties by facilitating growth inhibition and destruction of tumor cells. While the mechanism of their antitumor actions is still not completely understood, stimulation and modulation of key host immune responses by these mushroom polymers appears central. Particularly and most importantly for modern medicine are polysaccharides with antitumor and immunostimulating properties. Several of the mushroom polysaccharide compounds have proceeded through phases I, II, and III clinical trials and are used extensively and successfully in Asia to treat various cancers and other diseases. A total of 126 medicinal functions are thought to be produced by medicinal mushrooms and fungi including antitumor, immunomodulating, antioxidant, radical scavenging, cardiovascular, antihypercholesterolemia, antiviral, antibacterial, antiparasitic, antifungal, detoxification, hepatoprotective, and antidiabetic effects.
本综述的目的是提请人们注意在二十一世纪药用蘑菇科学未来发展中存在的许多极为重要的未解决问题。特别关注蘑菇多糖。许多,如果不是所有的,高等担子菌蘑菇在子实体、培养菌丝体和培养肉汤中都含有生物活性多糖。总结了约 700 种高等异担子菌和同担子菌的蘑菇多糖数据。讨论了多糖的化学结构及其与抗肿瘤活性的关系,包括化学修饰的可能途径、抗肿瘤或免疫刺激多糖的实验测试和临床应用以及其生物学作用的可能机制。描述了许多来自药用蘑菇的具有生物活性的多糖或多糖-蛋白质复合物,这些复合物似乎增强了先天和细胞介导的免疫反应,并在动物和人类中表现出抗肿瘤活性。药用蘑菇生物活性聚合物刺激宿主免疫防御系统对宿主中许多种免疫细胞的成熟、分化和增殖具有重要影响。许多先前报道的这些蘑菇聚合物具有免疫治疗特性,通过促进肿瘤细胞的生长抑制和破坏来发挥作用。尽管其抗肿瘤作用的机制尚不完全清楚,但这些蘑菇聚合物对关键宿主免疫反应的刺激和调节似乎是核心。特别是对现代医学来说,具有抗肿瘤和免疫刺激特性的多糖尤为重要。几种蘑菇多糖化合物已经通过 I、II 和 III 期临床试验,并在亚洲被广泛成功地用于治疗各种癌症和其他疾病。药用蘑菇和真菌具有 126 种药用功能,包括抗肿瘤、免疫调节、抗氧化、清除自由基、心血管、抗高胆固醇血症、抗病毒、抗菌、抗寄生虫、抗真菌、解毒、保肝和抗糖尿病作用。